18-2656115-G-A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_015295.3(SMCHD1):c.40G>A(p.Val14Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000862 in 1,461,246 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015295.3 missense
Scores
Clinical Significance
Conservation
Publications
- arhinia, choanal atresia, and microphthalmiaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics, ClinGen, Illumina
- facioscapulohumeral muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMCHD1 | NM_015295.3 | c.40G>A | p.Val14Met | missense_variant | Exon 1 of 48 | ENST00000320876.11 | NP_056110.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMCHD1 | ENST00000320876.11 | c.40G>A | p.Val14Met | missense_variant | Exon 1 of 48 | 5 | NM_015295.3 | ENSP00000326603.7 | ||
SMCHD1 | ENST00000688342.1 | c.40G>A | p.Val14Met | missense_variant | Exon 1 of 47 | ENSP00000508422.1 | ||||
SMCHD1 | ENST00000684915.1 | n.197G>A | non_coding_transcript_exon_variant | Exon 1 of 14 | ||||||
ENSG00000293256 | ENST00000733457.1 | n.-245C>T | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152168Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000699 AC: 9AN: 128698 AF XY: 0.0000415 show subpopulations
GnomAD4 exome AF: 0.0000924 AC: 121AN: 1308964Hom.: 0 Cov.: 29 AF XY: 0.0000961 AC XY: 62AN XY: 645478 show subpopulations
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152282Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74474 show subpopulations
ClinVar
Submissions by phenotype
Facioscapulohumeral muscular dystrophy 2 Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 14 of the SMCHD1 protein (p.Val14Met). This variant is present in population databases (rs559283578, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SMCHD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 286236). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.40G>A (p.V14M) alteration is located in exon 1 (coding exon 1) of the SMCHD1 gene. This alteration results from a G to A substitution at nucleotide position 40, causing the valine (V) at amino acid position 14 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at